Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009167HBVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20012030HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20036049HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20056806HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS44025067HTLV-1ENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TCGA Plot Options
Drug Information
GeneSCN5A
DrugBank IDDB00280
Drug NameDisopyramide
Target IDBE0000197
UniProt IDQ14524
Regulation Typeinhibitor
PubMed IDs15897781; 15028073; 11196553; 11752352
CitationsSugao M, Fujiki A, Nishida K, Sakabe M, Tsuneda T, Iwamoto J, Mizumaki K, Inoue H: Repolarization dynamics in patients with idiopathic ventricular fibrillation: pharmacological therapy with bepridil and disopyramide. J Cardiovasc Pharmacol. 2005 Jun;45(6):545-9.@@Fujiki A, Sugao M, Nishida K, Sakabe M, Tsuneda T, Mizumaki K, Inoue H: Repolarization abnormality in idiopathic ventricular fibrillation: assessment using 24-hour QT-RR and QaT-RR relationships. J Cardiovasc Electrophysiol. 2004 Jan;15(1):59-63.@@Shimizu W, Antzelevitch C, Suyama K, Kurita T, Taguchi A, Aihara N, Takaki H, Sunagawa K, Kamakura S: Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2000 Dec;11(12):1320-9.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved
Direct ClassificationPheniramines
SMILESCC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C
PathwaysDisopyramide Action Pathway
PharmGKBPA449373
ChEMBLCHEMBL517